Ceres Inc  

(Public, NASDAQ:CERE)   Watch this stock  
Find more results for CERE
8.25
-0.03 (-0.36%)
Real-time:   10:06AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.25 - 8.30
52 week 7.20 - 18.70
Open 8.25
Vol / Avg. 404.00/19,939.00
Mkt cap 202.07M
P/E     -
Div/yield     -
EPS -1.67
Shares 24.49M
Beta     -
Inst. own 71%

Key stats and ratios

Q2 (May '12) 2011
Net profit margin -733.10% -549.21%
Operating margin -703.66% -376.33%
EBITD margin - -344.97%
Return on average assets -40.77% -87.09%
Return on average equity -46.53% -
Employees 98 -
Carbon Disclosure Rating - -

Address

1535 Rancho Conejo Boulevard
Thousand Oaks, CA 91320
United States - Map
+1-805-3766500 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company�s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomass sorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.

Officers and directors

Walter De Logi Ph.D. Independent Chairman of the Board
Bio & Compensation - Reuters
Richard Hamilton Ph.D. President, Chief Executive Officer, Director
Bio & Compensation - Reuters
Paul M. Kuc Chief Financial Officer
Bio & Compensation - Reuters
Wilfriede van Assche Senior Vice President, General Counsel, Secretary
Bio & Compensation - Reuters
Michael Stephenson Vice President - Operations
Bio & Compensation - Reuters
J. Jefferson Gwyn Ph.D. Vice President - Breeding and Genomics
Bio & Compensation - Reuters
Roger Pennell Ph.D. Vice President - Trait Development
Bio & Compensation - Reuters
Richard Flavell Ph.D. CBE Chief Scientific Officer, Director
Bio & Compensation - Reuters
Cheryl P. Morley Director
Bio & Compensation - Reuters
Douglas Suttles Director
Bio & Compensation - Reuters